Lowered levels of serum albumin and HDL-cholesterol in children with a recent mild infection

Annals of Medicine

Volumn 38, Issue 2, 2006, Pages 154-160

  Aburawi, Elhadi H ^a   Grubb, Anders ^a   Raitakari, Olli T ^b   Viikari, Jorma ^b   Pesonen, Erkki J ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Acute phase proteins; Atherosclerosis; Coronary heart disease; Infection

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OROSOMUCOID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY RISK; DISEASE SEVERITY; FOLLOW UP; HUMAN; INFECTION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CHILD; CHOLESTEROL, HDL; FEMALE; HUMANS; INFECTION; INFLAMMATION; MALE; RISK FACTORS; SERUM ALBUMIN;

EID: 33645507969     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890500358343     Document Type: Article

References (29)

1. Pesonen E, Liuba P. Footprints of atherosclerotic coronary heart disease in children. Rev Port Cardiol. 2004;23:127-31.
2. Libby P, Egan D, Skarlatos S. Role of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997;96:4095-103.
3. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol. 2000;85:140-6.
4. Kovanen PT. Atheroma formation: defective control in the intimal round-trip of cholesterol. Eur Heart J. 1990;11(Suppl E): 238-46.
5. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkilä E, Taskinen M-R. Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 1988;119:557-61.
6. Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison R C. Serum albumin and risk of myocardial infarction and all cause mortality in the Framingham offspring study. Circulation. 2002;106:2919-24.
7. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-54.
8. Zoellner H, Hofler M, Beckman R, Hufnagl P, Vanyek E, Wojta J, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci. 1996;109:2571-80.
9. Belayev L, Zhao W, Pattany PM, Weaver RG, Huh PW, Lin B, et al. Diffusion weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Stroke. 1998;29:2587-99.
10. Kuller LH, Eicner JE, Orcard TJ, Grandits GA, McCallum, Tracy RP. The relation between serum albumin levels and risk of coronary heart disease in the multiple risk factor intervention trial. Am J Epidemiol. 1991;134:1266-77.
11. Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol. 2003;24:122-6.
12. Viikari J, Rönnemaa T, Seppänen A, Marniemi J, Porkka K, Räsänen L, et al. Serum lipids and lipoproteins in children, adolescents and young adults in. 1980-1986. Ann Med. 1991;23:53-9.
13. Siegel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW. Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem. 1981;19:838-9.
14. Kostner GM. Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by polyanion precipitation. Clin Chem. 1976;22:695.
15. Friedewald WT, Levy R, Fredrickson DS, Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
16. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference material (CRM 470). International federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem. 1996;34:517-20.
17. SAS/STAT User's Guide. Cary NC: SAS Institute Inc, 1998.
18. Pesonen E, Rapola J, Viikari J, Turtinen J, Åkerblom HK. Altered serum lipid profile after systemic infection in children: risk factor for CHD? Eur Heart J. 1993;14(Suppl K): 7-11.
19. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med. 1976;295:369-77 and 420-5.
20. Korppi M. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: What is the most accurate combination? Pediatr Int. 2004;46:545-50.
21. Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes. 1992;41(Suppl 2): 97-101.
22. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis. 2000;181(Suppl 3): 462-72.
23. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM. High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation. 2001;103:2283-8.
24. Liuba P, Persson J, Luoma J, Ylä-Herttuala S, Pesonen E. Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media. Eur Heart J. 2003;24:515-21.
25. Laaksonen R, Janatuinen T, Vesalainen R, Lehtimäki T, Elovaara I, Jaakkola O, et al. High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults. Eur J Clin Invest. 2002;32:795-802.
26. Zhang WJ, Frei B. Albumin selectively inhibits TNFalpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55:820-9.
27. Shimamoto T. The relationship of edematous reaction in arteries to atherosclerosis and thrombosis. J Atheroscler Res. 1963;3:87-102.
28. Reuben DB, Ferrucci L, Wallace R, Tracy RB, Corti MC, Heimovitz H, et al. The prognostic value of serum albumin in healthy older persons with low and high serum interleukin-6 (IL-6) levels. J Am Geriatr Soc. 2000;48:1404-7.
29. Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison C. Effects of serum Albumin and Bilirubin on the Risk of Myocardial Infarction (the Framingham Offspring Study). Am J Cardiol. 2003;91:485-8.